Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - YES.

Authors :: Freedman M
Atkins HL
Source :: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2016 Sep; Vol. 22 (10), pp. 1258-9. Date of Electronic Publication: 2016 Jul 21.
Publication Year :: 2016

Subjects :: Hematopoietic Stem Cells cytology
Humans
Risk
Transplantation, Autologous
Hematopoietic Stem Cell Transplantation methods
Hematopoietic Stem Cells immunology
Multiple Sclerosis therapy

Full Text Access

Tools